Find Academic Supervisors

Rotem Karni, PhD, is an Associate Professor of Genetics at the Perelman School of Medicine, University of Pennsylvania, Philadelphia. He leads a research lab focused on understanding how alternative RNA splicing contributes to cancer and genetic diseases, with a strong emphasis on translating these findings into RNA-based therapies. Karni's lab develops decoy oligonucleotides, small molecules, and splice-switching technologies to modulate splicing factors and enhance immunotherapy. Education BSc in Biological Chemistry from The Hebrew University of Jerusalem (1997) PhD in Biological Chemistry from The Hebrew University of Jerusalem, Israel (2002) Postdoctoral Fellowship at Cold Spring Harbor Laboratory, NY (2002-2007) Karni's research explores the deregulation of alternative splicing in oncogenesis, particularly how splicing factors like RBFOX2 and S6K1 influence metastasis, DNA repair, and immune checkpoint modulation. His team investigates m6A RNA modifications for stabilizing mutant genes, with applications in Duchenne Muscular Dystrophy and pancreatic cancer. The lab's work is commercialized through biotech companies: SKIP Therapeutics, Andlit Therapeutics, and RNAble. Selected Research Trends RNA mis-splicing and neoantigen generation (2025) Splicing factor inhibition for tumor suppression (2023) Metastatic splicing signatures in pancreatic cancer (2023) Immune checkpoint splicing in cancer immunotherapy (2021) m6A modulation for mRNA stabilization (2023) Advising & Collaborations Karni has mentored numerous PhD and postdoctoral researchers, many of whom now hold leadership roles in academia, biotech, and medical institutions globally. His lab collaborates extensively on projects involving RNA innovation, including partnerships with the Institute for RNA Innovation. Contact Department of Genetics & Institute for RNA Innovation, One uCity Square, Room 4018, Philadelphia, PA 19104 Phone: 215-898-5072 Email: Rotem.Karni@Upenn.edu

• Alternative RNA Splicing
• RNA Biology
• Cancer Therapy
• +4 more

Katie L. Kaput is a Clinical Associate Professor in the Department of Internal Medicine at the University of Utah School of Medicine. She provides high-quality, personalized endocrine care with a focus on preventative health and chronic illness management at the Sugar House Health Center in Salt Lake City, Utah. Education: Bachelor's in Biology from the University of Georgia, Medical Degree from Michigan State College of Osteopathic Medicine, Residency at National Jewish Health/Saint Joseph Hospital, and Endocrinology Fellowship at the University of Utah. Research & Clinical Interests: Span endocrinology and internal medicine, with expertise in Adrenal and Parathyroid Disorders Osteoporosis & Metabolic Bone Disease Thyroid and Pituitary Disorders Transgender Health Cystic Fibrosis Endocrinology Clinical Excellence: Patient testimonials highlight her exceptional bedside manner, expertise, and patient-centered approach. She works alongside Heather and Kaj, noted for their professionalism and care.

• Endocrinology
• Internal Medicine
• Metabolic Disorders
• +9 more

Sergio Infante, MD, is an Associate Professor in the Department of Medicine at the School of Medicine and an Assistant Professor in the Department of Pharmacy Practice at the School of Pharmacy, both at Loma Linda University. His dual appointment reflects his interdisciplinary expertise in clinical nephrology and pharmacy practice, particularly in managing patients with kidney disease and optimizing medication regimens in renal impairment. Associate Professor, Department of Medicine, School of Medicine, Loma Linda University Assistant Professor, Department of Pharmacy Practice, School of Pharmacy, Loma Linda University Dr. Infante's research focuses on nephrology, transplantation, and pharmaceutical care in chronic and critical illness. His work addresses key clinical challenges such as drug dosing in continuous renal replacement therapy, bone health in dialysis patients, outcomes in kidney transplant recipients, and mental health in end-stage renal disease. He also investigates interdisciplinary models of care to improve patient adherence and outcomes in dialysis. His recent publications (2017–2024) demonstrate consistent scholarly output across nephrology, pharmacy, and internal medicine journals. These studies include case reports, clinical research, and interdisciplinary reviews, with a strong emphasis on practical applications in patient management. Themes in his research include mineral and bone disorders in CKD, ultrafiltration strategies, post-transplant complications, and the intersection of mental health with chronic kidney disease. Dr. Infante has been actively involved in multiple research projects, including investigator roles in industry-sponsored and internally funded studies. Notably, he served as Principal Investigator (PD/PI) on a grant from LLU-GRASP (2021–2025) examining lithium use in depression and suicidal ideation among ESRD patients, indicating leadership in psychonephrology research. Evaluation of polymyxin B hemoperfusion in septic shock (EUPHRATES) – Investigator (Spectral Diagnostics Inc., 2014–2015) Assessment of kidney disease in COVID-19 patients – Investigator (LLU Dept. of Medicine, 2021) Literacy and numeracy in dialysis medication labeling – Investigator (LLU Dept. of Pharmacy, 2019) Clinical outcomes of induction therapies in transplant patients – Investigator (LLU Transplantation Institute, 2007–2015) Role of lithium in depression in ESRD – PD/PI (LLU-GRASP, 2021–2025) While no formal lab or team is explicitly mentioned, his collaborative publications and project leadership suggest active participation in multidisciplinary research teams involving nephrology, pharmacy, psychiatry, and transplantation. His future work appears to focus on mental health in renal populations, patient education, and precision dosing in critical care nephrology.

• Nephrology
• Pharmacy Practice
• Internal Medicine
• +12 more

Trenton R. Foster, M.D., is an Associate Professor of Surgery at Mayo Clinic College of Medicine, serving as a Consultant in the Division of Endocrine Surgery within the Department of Surgery. He holds multiple leadership positions including Associate Program Director for the General Surgery Residency Program and Associate Director of Student Clerkships Programs. Dr. Foster is also the Physician Lead for the Collaborative Endocrine Surgery Quality Improvement Program (CESQIP) and serves on several important committees including the Clinical Competency Committee and the Department of Surgery Equity, Inclusion, and Diversity Committee. Dr. Foster's research focuses on optimizing surgical management of endocrine disorders, with particular emphasis on determining appropriate surgical extent for thyroid cancer, improving preoperative localization for parathyroid disease, and refining diagnostic approaches for adrenal tumors. His work utilizes national and institutional databases to understand disease behavior and improve patient outcomes through evidence-based practice. Analysis of Dr. Foster's recent publications (2023-2025) reveals a strong focus on clinical outcomes research across the spectrum of endocrine surgery. His work addresses critical questions regarding optimal surgical approaches for thyroid, parathyroid, and adrenal conditions, with particular attention to minimally invasive techniques, long-term outcomes, and quality improvement initiatives. The research demonstrates expertise in analyzing complex surgical datasets to derive practical clinical insights that directly impact patient care. His scientific achievements include: 2025 Focused Practice Designation in Adult Complex Thyroid and Parathyroid Surgery from the American Board of Surgery 2019 Dennis Wasson, M.D. Award for Outstanding Graduating Chief Resident from Yale University Multiple research awards from 2015-2016 including the SVS Foundation Resident Research Prize and Department of Surgery Best Basic Science Research Award at Yale Golden Key National Honor Society membership during undergraduate studies Dr. Foster actively mentors residents and medical students through his roles in the General Surgery Residency Program and student clerkships. He collaborates extensively with colleagues in endocrinology, radiology, and pathology to provide comprehensive, multidisciplinary care for patients with endocrine disorders. His research directly informs clinical practice, leading to improved preoperative evaluation, optimized surgical approaches, and enhanced postoperative care protocols while maintaining safety and effectiveness.

• Endocrine Surgery
• Thyroid Surgery
• Parathyroid Surgery
• +7 more

Dr. Richard H. Wiggins serves as Professor of Radiology and Imaging Sciences at the University of Utah School of Medicine, where he also holds the position of Associate Dean of Continuing Medical Education. He maintains adjunct professorships in Otolaryngology, Head and Neck Surgery, and Biomedical Informatics. His educational background includes a BA in Biochemistry from the University of Texas at Austin and an MD from the University of Texas at Houston Health Sciences Center, followed by specialized training at the University of Florida and University of Utah. Dr. Wiggins's research spans neuroradiology, biomedical informatics, and medical education innovation. His work explores advanced imaging techniques for head and neck pathologies, PET-CT applications in oncology, and the development of novel educational platforms like the RadDiscord community. He maintains particular expertise in temporal bone imaging, paragangliomas, and thyroid nodule classification systems. Analysis of his recent publications shows strong emphasis on: (1) optimizing oncologic imaging protocols, especially PET-CT applications across cancer types; (2) advancing head and neck radiology through volumetric analysis and radiomics; and (3) transforming radiology education via gamification and digital communities. His scientific honors include: Distinguished Teaching Award (Otolaryngology, University of Utah) Honored Educator Award (Radiological Society of North America) Inaugural Fellow, Academy of Health Science Educators 25th Fellow of the Society of Imaging Informatics in Medicine Fellow of the American College of Radiology He leads the Utah Head and Neck Imaging Center of Excellence, which includes an educational YouTube channel (@UHNICE). While specific grants aren't detailed, his extensive lecture record (600+ presentations) and leadership roles in professional societies like SIIM (Program Chair 2014-2020), ASHNR (Past President), and WNRS (Past President) demonstrate significant academic influence.

• Neuroradiology
• Biomedical Informatics
• Head and Neck Imaging
• +3 more

Prof. Dr. Andreas Pfeiffer is a faculty member at Charité – Universitätsmedizin Berlin , affiliated with the Campus Benjamin Franklin and the Department of Endocrinology, Diabetes and Nutritional Medicine . His research focuses on nutrition and hormones , endocrine disorders of organs like the thyroid, parathyroid, pituitary gland, and adrenal gland, as well as the intersection of obesity , overweight diabetes , and nutritional medicine with an emphasis on diabetes remission . Research Interests : Hormone-producing organ diseases; obesity-related metabolic disorders; nutritional medicine for diabetes management. Contact : andreas.pfeiffer@charite.de | Tel: +49 30 450 514 422

• Endocrinology
• Diabetes
• Nutritional Medicine
• +3 more

David C. Shonka, Jr., MD is an Associate Professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Virginia (UVA). He is a fellowship-trained head and neck endocrine and oncologic surgeon specializing in thyroid cancer, parathyroid surgery, and complex head and neck malignancies. Primary Education: University of Virginia School of Medicine Residency: University of Virginia School of Medicine Fellowship: University of Iowa Roy J. and Lucille A. Carver College of Medicine His research focuses on: Thyroid and parathyroid disorders Quality metrics in endocrine surgery Transoral robotic surgery outcomes Cancer tumor biomarkers Medical imaging modalities Recent publications analyze ablation technologies, mutational testing, and imaging innovations for thyroid and parathyroid conditions. Scientific awards include the 2019 Best Bedside Manner Award and inclusion in the Best Doctors in America® List (2017-2020). He actively mentors medical students and residents in clinical research and serves on national endocrine surgery committees. American Head and Neck Society American Thyroid Association American Academy of Otolaryngology-Head and Neck Surgery American College of Surgeons Dr. Shonka provides interdisciplinary care with endocrinologists, radiation oncologists, and medical oncologists. He offers office-based diagnostics like ultrasound and needle biopsies while performing high-complexity surgeries post-radiation or prior surgery.

• Endocrine Surgery
• Head and Neck Oncology
• Thyroid Cancer
• +4 more

Dr. Imali Sirisena is a Clinical Professor of Medicine at the Lewis Katz School of Medicine at Temple University, where she serves as Program Director for the Endocrinology Fellowship program. She practices clinical endocrinology with Temple Health in Philadelphia, Pennsylvania. Her educational background includes: MD from New York Medical College, Valhalla, NY MS in Physiology from Georgetown University, Washington, DC Dr. Sirisena's clinical expertise spans multiple areas of endocrinology with particular focus on thyroid disorders, metabolic bone diseases, and diabetes management. She maintains active board certifications in both Internal Medicine and Endocrinology, Diabetes and Metabolism through the American Board of Internal Medicine. Patient satisfaction ratings consistently show exceptional care quality with a 4.8 out of 5 rating based on 176 patient surveys. Patients describe her as caring, informative, and responsive to their concerns and questions. Professional affiliations include: Endocrine Society Philadelphia Endocrine Society American Association of Clinical Endocrinologists As Program Director of the Endocrinology Fellowship, Dr. Sirisena plays a key role in training the next generation of endocrinologists while maintaining an active clinical practice focused on comprehensive care for patients with complex endocrine disorders across multiple Temple Health locations in Philadelphia.

• Endocrinology
• Thyroid disease
• Thyroid nodules
• +6 more

Dr. Amber L. Beitelshees is an Associate Professor of Medicine in the Division of Endocrinology, Diabetes and Nutrition at the University of Maryland School of Medicine. With a PharmD from the University of Florida and an MPH in epidemiology, she completed a residency in Pharmacy Practice at the University of Illinois Medical Center at Chicago followed by a postdoctoral fellowship in Cardiovascular Pharmacogenomics. Previously, she served on the faculty at Washington University in St. Louis School of Medicine and the University of Florida College of Pharmacy before joining her current institution. Dr. Beitelshees' research focuses on understanding interpatient variability in drug response, particularly through pharmacogenomics. She leverages genetic epidemiology, clinical pharmacology, and functional genomics to investigate treatment responses in cardiovascular disease and diabetes. Her work examines how understanding variability in drug response can provide mechanistic insights into disease biology and explores approaches for implementing pharmacogenetics into routine clinical care. She actively serves on the Pharmacogenetics Service and the Pharmacogenetics subcommittee of the P&T committee to facilitate the clinical implementation of pharmacogenetic tests. Analysis of her recent publications reveals a strong emphasis on precision medicine applications in cardiology and endocrinology. Her research spans pharmacogenetics of antihypertensive medications, diabetes treatments including SGLT2 inhibitors and GLP-1 receptor agonists, and antiplatelet therapy optimization. A notable trend is her increasing focus on racial disparities in drug response, particularly in cardiovascular treatments for Black patients, and the development of clinical implementation strategies for pharmacogenetic testing. In her clinical role, Dr. Beitelshees contributes to pharmacogenetic service implementation and serves on relevant committees. Her collaborative work spans numerous institutions through consortia like the IGNITE Pharmacogenetics Working Group, demonstrating her leadership in translating pharmacogenomic research into clinical practice. Her laboratory utilizes a multidisciplinary approach combining genetic epidemiology with clinical pharmacology to address questions of drug response variability.

• Pharmacogenetics
• Pharmacogenomics
• Cardiovascular Disease
• +5 more

Kepal N. Patel, MD, is a Professor in the Departments of Surgery, Biochemistry and Molecular Pharmacology, and Otolaryngology-Head and Neck Surgery at NYU Grossman School of Medicine. He serves as Vice Chair for Faculty Development in the Department of Surgery and Chief of the Division of Endocrine Surgery. His clinical expertise includes endocrine and head and neck cancer surgery, with a focus on thyroid and parathyroid conditions. He leads interdisciplinary teams at Perlmutter Cancer Center to develop personalized care plans for thyroid tumors and advocates for tailored surgical approaches. Dr. Patel’s research investigates molecular mechanisms underlying thyroid carcinoma progression, aiming to identify prognostic markers and therapeutic targets. He holds leadership roles in professional organizations, including co-chair of the Surgical Affairs Committee for the American Thyroid Association and secretary of the New York Head and Neck Society. His education includes an MD from Rutgers University (1996), residency in General Surgery at Rutgers Robert Wood Johnson Medical School (2002), and a Head & Neck Surgery fellowship at Memorial Sloan-Kettering Cancer Center (2004). He is board-certified in General Surgery (American Board of Surgery, 2003).

• Thyroid Cancer Research
• Molecular Pathogenesis
• Genomic Medicine
• +3 more

Simona Gauduseviciene is a Clinical Assistant Professor at the Department of Clinical Medicine, Faculty of Medicine, Aalborg University, and a senior clinician (Overlæge) at Aalborg University Hospital in Denmark. Her clinical and academic work is centered on endocrine disorders, particularly parathyroid diseases. Research Interests: Her primary research focuses on the diagnosis and management of rare parathyroid tumors, especially water clear cell parathyroid adenomas. She investigates advanced imaging techniques for preoperative localization, including methionine-based PET-CT, to improve surgical outcomes in patients with primary hyperparathyroidism. Her work bridges clinical practice and academic research in endocrinology and nuclear medicine. Recent Research Trends: Her 2024 case report highlights the use of molecular imaging in localizing giant water clear cell parathyroid adenomas, contributing to the understanding of rare endocrine tumors and optimizing diagnostic pathways. This reflects a trend toward precision localization in endocrine surgery using advanced imaging modalities. Scientific Awards: No awards mentioned. Advising and Grants: No information available regarding student supervision, mentoring, or grant funding. Labs and Teams: She collaborates within the Department of Clinical Medicine and Aalborg University Hospital’s endocrine and radiology teams, contributing to clinical research in parathyroid disorders and imaging innovation.

• Endocrinology
• Thyroid and Parathyroid Disorders
• Primary Hyperparathyroidism
• +7 more

Dr. Isis W. Gayed is an Adjunct Professor in the Radiology & Imaging Sciences department. She is a board-certified nuclear medicine physician with additional certification in nuclear cardiology. Education: MBBS from Faculty of Medicine, University of Khartoum Fellowship at Baylor College of Medicine Residency at Baylor College of Medicine Internship at Hahnemann University Hospital Graduate Training at Michener Institute School of Applied Health Sciences Post-Graduate Training at Toronto General Hospital Research Interests: Nuclear medicine applications in cancer imaging (PET-CT, SPECT/CT) Cardiovascular imaging in oncology patients Diagnostic accuracy of imaging modalities Lymphatic mapping and sentinel node detection Functional imaging for treatment planning Endocrine and parathyroid imaging Publication Trends: Over 20 peer-reviewed articles in clinical nuclear medicine Focus areas: oncology imaging, cardiovascular nuclear medicine, diagnostic techniques Collaborative research with surgical and oncology departments Methodological improvements in SPECT/CT and PET-CT applications Longitudinal studies on radiation therapy outcomes Technical innovations in parathyroid and breast cancer imaging Professional Background: Board certifications in nuclear medicine and nuclear cardiology Extensive clinical training across North America Primary research focus on hybrid imaging modalities (SPECT/CT, PET/CT) Contributions to cancer imaging guidelines and treatment protocols

• Nuclear Medicine
• Medical Imaging
• Oncology
• +5 more

Dr. Juan M Taboas is an Associate Professor at the University of Pittsburgh, affiliated with the School of Dental Medicine (Department of Oral and Craniofacial Sciences), Swanson School of Engineering (Department of Biomedical Engineering), and the Clinical and Translational Science Institute. His research focuses on regenerative therapies for skeletal and craniofacial tissues, particularly in pediatric populations and underserved communities. Education: B.S. Mechanical Engineering (University of Miami, 1993), M.S. Biomechanical Engineering (Stanford, 1995), dual M.S./Ph.D. Biomedical Engineering (University of Michigan, 2003/2004). Postdoctoral training at NIST and NIAMS/NIH. Research Interests include physeal regeneration for growth plate injuries, dental pulp regeneration via injectable biomaterials, and microtissue fabrication for drug screening. His lab holds patents for regenerative therapies and microfluidic culture systems. He collaborates widely, leading multi-site NIH/DoD grants. Professional Activities: Senior Member of the National Academy of Inventors, reviewer for NIH/DoD grants, and journal manuscripts (e.g., Acta Biomaterialia, Journal of Dental Research). Serves on the University of Pittsburgh Senate. Article Trends span biomaterial design, immunomodulation, and mechanistic studies of bone/cartilage regeneration. Recent work emphasizes pediatric applications and translational therapies for skeletal disorders.

• Regenerative Medicine
• Biomedical Engineering
• Tissue Engineering
• +4 more

Quansheng Du is an Associate Professor at the Medical College of Georgia , affiliated with the Department of Neuroscience and Regenerative Medicine and the Department of Neurology . His academic appointments include teaching responsibilities in advanced molecular biology courses such as BIOM 8230 Biology of Proteins in Disease and BIOM 8022 Molecular Cell Biology . Education: Ph.D., Molecular Biology, Wuhan University (1999) MS, Molecular Biology, Wuhan University (1995) Research Interests span molecular mechanisms in neurological diseases, regenerative medicine, and metabolic pathways in cancer cachexia. His work includes studies on genetic disorders (MRKH syndrome), microRNA roles in neuronal survival, purine synthesis inhibition in pulmonary hypertension, and TEAD1 signaling in cardiomyocyte protection. Recent Publications (2021–2024) focus on molecular biology intersections with neuroscience, cardiovascular diseases, and cancer metabolism, with recurring themes in genetic regulation, cellular reprogramming, and metabolic dysregulation.

• Molecular Biology
• Neuroscience
• Regenerative Medicine
• +5 more

Susan K. Hobbs, MD, PhD is a Professor at the University of Rochester Medical Center (URMC) within the Department of Imaging Sciences and Associate Dean for Equity and Inclusion in the School of Medicine and Dentistry. She specializes in cardiothoracic imaging and resident education. Harvard Medical School (MD) Massachusetts Institute of Technology (PhD in Chemical Engineering) Undergraduate in Chemical Engineering from University of Minnesota Her research focuses on tumor angiogenesis, novel imaging biomarkers, and diagnostic imaging applications in pulmonary diseases, oncologic thoracic processes, cardiovascular disease, and parathyroid disorders. She has pioneered programs in Cardiac MRI and Lung Cancer Screening at URMC. Dr. Hobbs' publications highlight expertise in chest imaging , CT methodology , tumor proteomics , and radiologic education . Key contributions include bone suppression techniques, pulmonary artery imaging, and image-guided proteomic analysis. Best Conference Teachers Award (2015) Arvin Robinson Teaching Award (2014-2015) TAVI Team Service Excellence Award (2014) NIH Fellowships (1994-1998) AACR Scholarships (1997-1998) Dr. Hobbs actively contributes to resident education and serves on multiple professional societies including the Society of Thoracic Radiology and RSNA. She acts as a reviewer for NIH and Radiology journal.

• Diagnostic Imaging
• Cardiothoracic Imaging
• Tumor Angiogenesis
• +5 more